Clinical Trial Update: ZEBOVAC (Ebola Vaccine Trial, Ad26.ZEBOV/MVA-BN-Filo) [Phase 2]

View source ↗

Summary

Phase 2 trial update for the Ebola vaccine ZEBOVAC (Ad26.ZEBOV/MVA-BN-Filo) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebola Virus Disease

Drugs mentioned

• Ad26.ZEBOV/MVA-BN-Filo
• ZEBOVAC

Snippet

Sponsor: MRC/UVRI and LSHTM Uganda Research Unit | Conditions: Ebola Virus Disease | Phase 2 | Status: COMPLETED